Montavit pharmaceutical company was founded on 16 November 1945 in Austria by Daniel Swarovski and Dr. Alfred Fröhlich with Dr. Albin Meyer as CEO. In 1951, the company introduced its first antihistamine product, and in 1965 received a patent for the antispasmodic substance salverin. During the expansion of the company in 1999, trade branches were opened in Bulgaria and Russia, and in 2006 Romania and Serbia joined the company’s family. Since 2013, the next generation has joined the management of the company - Katerina Schmid.
Montavit is represented on four continents through its products in over 80 countries around the world. Among the main highlights is the expansion and improvement of economic indicators through partnerships with local distributors and their own marketing offices in some countries. For the last 20 years, the company has grown, establishing branches in Bulgaria, Russia, Ukraine, Serbia and Romania. Our main areas of activity are urology, pulmonology, gastroenterology, gynecology, allergy treatment and others in the field of herbal medicines. Patients around the world trust the reliable efficiency of our products.
On 15 November 2019, Montavit celebrated its twentieth anniversary in the Bulgarian market. For the last 20 years the company has managed to provide the Bulgarian market with innovative products without analog that are in the interest of patients while contributing to the development of this country‘s pharmaceutical industry.
